Clinical trials: sponsored by UMC Utrecht
Coronary Artery Disease (CAD), Obstructive Coronary Artery Disease
Comprehensive Invasive Physiological Evaluation of Obstructive Coronary Artery Disease
The goal of this clinical trial is to test whether adding coronary function testing and starting targeted medical treatment for identified vasomotor disorders will also improve angina symptoms and quality of life in patients with…
- Conditions
- Coronary Artery Disease (CAD), Obstructive Coronary Artery Disease, Coronary Microvascular Dysfunction (CMD), Vasospasm, Coronary
- Trial name
- NCT07449052
- Testing
- Coronary function testing, Percutaneous coronary intervention
- Volunteers
- 450 people
- Sponsor
- UMC Utrecht
Diffuse Midline Glioma, H3 K27-Altered
Focused Ultrasound Blood-Brain Barrier Opening in Pontine Diffuse Midline Glioma to Enhance Temozolomide Therapy: Pilot Feasibility Study (FIDES)
This study is for people (children and adults) with a rare and aggressive brain tumor called H3K27-altered diffuse midline glioma (DMG) located in the pons, a deep part of the brainstem.
- Trial name
- FIDES (NCT07562971)
- Testing
- Focused Ultrasound (FUS) Blood-Brain Barrier Opening, Temozolomide (TMZ)
- Where
- 2 sites in Netherlands
- Volunteers
- 20 people
- Sponsor
- UMC Utrecht
Osteo Arthritis Knee
Use of a Putty as Gap Filler in Open-wedge Osteotomy
Rationale: Realignment osteotomies around the knee are a proven surgical treatment for unicompartmental knee osteoarthritis and a malalignment. Osteotomies can be very painful in the early postoperative phase.
- Trial name
- AXOS (NCT05992038)
- Testing
- Osteotomy with putty, Conventional osteotomy
- Where
- Netherlands
- Volunteers
- 40 people
- Sponsor
- UMC Utrecht
Adolescence Idiopathic Scoliosis
A Randomized Intra-Patient Controlled Trial of MagnetOs™ Putty vs Autograft in Instrumented Posterolateral Spinal Fusion in Idiopathic Scoliosis Patients
SUMMARY Rationale: Delayed union is a problem in adolescent idiopathic scoliosis (AIS) surgery, especially at the distal end of the construct.
- Trial name
- MAIS (NCT07512336)
- Testing
- MagnetOs putty 2.5cc, autograft
- Volunteers
- 140 people
- Sponsor
- UMC Utrecht
Systemic Sclerosis, Systemic Scleroses, Diffuse
Upfront Autologous HSCT Versus Immunosuppression in Early Diffuse Cutaneous Systemic Sclerosis
HSCT has been implemented in (inter)national treatment guidelines for diffuse cutaneous systemic sclerosis (dcSSc) and is offered in clinical care and reimbursed by national health insurance in several European countries.
- Conditions
- Systemic Sclerosis, Systemic Scleroses, Diffuse, Scleroderma, Scleroderma, Diffuse
- Trial name
- UPSIDE (NCT04464434)
- Testing
- Upfront autologous HSCT
- Where
- 8 sites in Italy, Netherlands and 1 more
- Volunteers
- 60 people
- Sponsor
- UMC Utrecht
Coronary Artery Disease, Angina (Stable)
Coronary Sinus Reducer Therapy for Persisting Angina
Refractory angina due to advanced obstructive coronary artery disease (CAD) remains a major clinical problem with limited evidence-based treatment options.
- Trial name
- REDUCE ANGINA (NCT07485985)
- Testing
- Coronary sinus reducer
- Volunteers
- 25 people
- Sponsor
- UMC Utrecht
Subarachnoid Hemorrhage, Spontaneous
Multicenter Registry of Patients With Subarachnoid Hemorrhage
The purpose of this registry is to collect detailed information on the characteristics, treatment, and outcomes of patients with a subarachnoid hemorrhage.
- Trial name
- MEASURE (NCT07482124)
- Testing
- None, observational study
- Where
- 9 sites in Netherlands
- Volunteers
- 1,000 people
- Sponsor
- UMC Utrecht
Bone Metastases
Prospective Evaluation of Interventional Studies on Bone Metastases - the PRESENT Cohort
Bone metastases are frequent distant manifestations of cancer, with pain as a common and devastating consequence. The primary treatment for painful bone metastases, external beam radiation therapy, is moderately effective: about…
- Trial name
- PRESENT (NCT02356497)
- Where
- Netherlands
- Volunteers
- 2,500 people
- Sponsor
- UMC Utrecht
Bone Metastases, Bone Neoplasm
Focused Ultrasound and RadioTHERapy for Noninvasive Palliative Pain Treatment in Patients With Bone Metastases
The FURTHER study aims to evaluate the effectiveness and cost-effectiveness of MR-HIFU (alone or in combination with EBRT) compared to EBRT alone, the standard-of-care, as a palliative treatment option to relieve CIBP.
- Conditions
- Bone Metastases, Bone Neoplasm, Bone Lesion, Bone Cancer
- Trial name
- FURTHER (NCT04307914)
- Testing
- External beam radiotherapy, MR-HIFU
- Where
- 6 sites in Finland, Germany and 2 more
- Volunteers
- 216 people
- Sponsor
- UMC Utrecht
Prostate Cancer
Utrecht Prostate Cohort for Cancer Treatment Intervention Studies and Long-term Evaluation
Rationale: Prostate cancer is the most common cancer in men worldwide. Survival rates are high due to the typically non-aggressive nature of disease and effective treatments.
- Trial name
- UPC (NCT04228211)
- Where
- 2 sites in Netherlands
- Volunteers
- 1,500 people
- Sponsor
- UMC Utrecht
Oncology, Breast Cancer
The MOMENTUM Study: The Multiple Outcome Evaluation of Radiation Therapy Using the MR-Linac Study
The Multi-OutcoMe EvaluatioN of radiation Therapy Using the Unity MR-Linac Study (MOMENTUM) is a multi-institutional, international registry facilitating evidenced based implementation of the Unity MR-Linac technology and further…
- Conditions
- Oncology, Breast Cancer, Prostate Cancer, Gynecologic Cancer
- Trial name
- MOMENTUM (NCT04075305)
- Testing
- Radiation therapy
- Where
- 18 sites in United States, Australia and 7 more
- Volunteers
- 8,000 people
- Sponsor
- UMC Utrecht
Prostate Cancer, Erectile Dysfunction Following Radiation Therapy
EREctile Function Preservation for Prostate Cancer Radiation Therapy (ERECT)
Single-arm phase II trial of 70 men with low- or intermediate-risk prostate cancer receiving magnetic resonance guided adaptive radiotherapy (MRgRT) in 5 fractions of 7.25 Gy, additionally sparing the neurovascular bundles, the…
- Trial name
- ERECT (NCT04861194)
- Testing
- Neurovascular-sparing
- Where
- Netherlands
- Volunteers
- 70 people
- Sponsor
- UMC Utrecht
Fahr Disease, Fahr Syndrome
Treatment of Ectopic Calcification in Fahr's Disease or Syndrome
Fahr's disease or syndrome are neurodegenerative diseases in which patients present with bilateral vessel associated calcifications in the basal ganglia.
- Conditions
- Fahr Disease, Fahr Syndrome, Primary Familial Brain Calcification
- Trial name
- CALCIFADE (NCT05662111)
- Testing
- Etidronate
- Where
- 2 sites in Netherlands, United Kingdom
- Volunteers
- 98 people
- Sponsor
- UMC Utrecht
Osteo Arthritis Knee and Hip
Predicting The Right Advice at The Right Time in Patients With Hip and Knee OsteoArthritis: the e-cOAch Cross-over.
This study aims to learn how symptoms and daily functioning change over time in people with hip or knee osteoarthritis (OA). The goal is to use this information to build computer models that can predict these changes.
- Trial name
- e-cOAch (NCT07423858)
- Testing
- Physical Activity program, Sleep program, Weight management program
- Where
- Netherlands
- Volunteers
- 600 people
- Sponsor
- UMC Utrecht
Esophageal Cancer
Laparoscopic Ischemic Conditioning Prior to Esophagectomy
This is a two center phase II prospective single-arm safety and feasibility trial for 20 patients with resectable esophageal carcinoma with an increased risk for anastomotic leakage, as based upon UCS and NASCET calcification…
- Trial name
- ISCON (NCT03896399)
- Testing
- Laparoscopic ischemic conditioning followed by esophagectomy
- Where
- 2 sites in Germany, Netherlands
- Volunteers
- 22 people
- Sponsor
- UMC Utrecht
Gastric Cancer
Laparoscopic Versus Open Gastrectomy for Gastric Cancer
This is the first randomized controlled trial comparing laparoscopic and open gastrectomy for resectable gastric cancer in a Western population.
- Trial name
- LOGICA (NCT02248519)
- Testing
- Open Gastrectomy, Laparoscopic Gastrectomy
- Where
- 10 sites in Netherlands
- Volunteers
- 210 people
- Sponsor
- UMC Utrecht
Cancer, Metastatic Cancer
Treatment of Cancer With Immune Checkpoint Inhibition Therapy Boosted by High Intensity Focused Ultrasound Histotripsy
This phase 1 clinical trial aims to evaluate the safety, tolerability and feasibility of combination treatment of High Intensity Focused Ultrasound Histotripsy (HIFU-HT) and immune checkpoint inhibitors (ICI) in adult patients…
- Trial name
- iFOCUS (NCT06524570)
- Testing
- HIFU-HT, ICI
- Where
- Netherlands
- Volunteers
- 24 people
- Sponsor
- UMC Utrecht
Esophageal Squamous Cell Carcinoma (ESCC), Esophageal Cancer, Squamous Cell
MR-Guided Radiotherapy Dose Escalation Trial for Esophageal Squamous Cell Carcinoma
SUMMARY Rationale: Esophageal cancer (EC) is the seventh most frequently diagnosed cancer and the sixth leading cause of cancer-related death worldwide.
- Trial name
- ESCALATE (NCT07359417)
- Testing
- Radiation: MRI guided radiotherapy
- Where
- Netherlands
- Volunteers
- 30 people
- Sponsor
- UMC Utrecht
Esophageal Adenocarcinoma, Esophageal Adenocarcinoma (EAC)
Combination of Chemotherapy and Adaptive MR-Guided Radiotherapy to Improve Outcomes in Patients With Esophageal Adenocarcinoma
Rationale: Esophageal cancer (EC) is the seventh most frequently diagnosed cancer and the sixth leading cause of cancer-related death worldwide.
- Conditions
- Esophageal Adenocarcinoma, Esophageal Adenocarcinoma (EAC), Adenocarcinoma - Gastroesophageal Junction (GEJ)
- Trial name
- MERGE (NCT07359443)
- Testing
- MRI guided radiotherapy
- Where
- Netherlands
- Volunteers
- 39 people
- Sponsor
- UMC Utrecht
Diabetes Mellitus, Type 1, Diabetes type1
Dual Hormone Closed Loop in Type 1 Diabetes
This study is a 12 month open-label, two-arm randomised parallel-group trial in adult type 1 diabetes patients executed in 14 centres in the Netherlands.
- Conditions
- Diabetes Mellitus, Type 1, Diabetes type1, Diabetes
- Trial name
- DARE (NCT05669547)
- Testing
- dual hormone fully closed loop (DHFCL)
- Where
- 14 sites in Netherlands
- Volunteers
- 243 people
- Sponsor
- UMC Utrecht